Conferences Alnylam Pharmaceuticals is attending in 2026
Alnylam Pharmaceuticals is listed at 2 conferences on Tnuki's calendar in 2026: TIDES Europe 2026 (on the program) and ASH 2026 (exhibiting). Alnylam Pharmaceuticals develops RNA interference therapeutics for genetic and other diseases. As of Sep 29, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
TIDES Europe 2026: Oligonucleotide & Peptide TherapeuticsOligonucleotide & peptide drug developersOfficial site |
Amsterdam, Netherlands ~900 attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 2 talks Attendee mix: Mostly industry; oligonucleotide and peptide R&D scientists, CMC and manufacturing specialists, regulatory and BD
Attending
|
Open the guide Search and filter attendees |
ASH 2026 Annual Meeting & ExpositionHematologists & blood cancer researchersOfficial site |
New Orleans, LA ~30k attendees | ExhibitorAs published by American Society of Hematology Booth 2313
Attendee mix: Mostly clinical; hematologists, KOLs, hematologic-oncology researchers, medical affairs and cell-therapy biopharma teams
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 29 of the 90 conferences on our calendar, so this page shows Alnylam Pharmaceuticals’s involvement at those 29 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Alnylam Pharmaceuticals
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!